NCT04181541

Brief Summary

The purpose of the study is to determine the safety and effectiveness of second trimester medical abortion when provided by nurse midwives compared with physicians. The study sample will be obtained from Michu Clinic, affiliated with St Paul's hospital, in Addis Ababa.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
245

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 22, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 29, 2019

Completed
3 months until next milestone

Study Start

First participant enrolled

February 17, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 24, 2021

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 3, 2021

Completed
Last Updated

September 20, 2021

Status Verified

September 1, 2021

Enrollment Period

1 year

First QC Date

November 22, 2019

Last Update Submit

September 17, 2021

Conditions

Keywords

Midlevel provider

Outcome Measures

Primary Outcomes (1)

  • Time to expulsion

    Time to expulsion of fetus after medical abortion regimen initiated

    Time (hours/minutes) from first dose of misoprostol until the fetus is expelled, up to 72 hours

Secondary Outcomes (5)

  • Total number of misoprostol doses

    Time (hours/minutes) from first dose of misoprostol until the fetus and placenta are expelled, up to 72 hours

  • Need for ultrasound to confirm gestational age

    At the time of eligibility for the abortion is assessed, need for confirmatory ultrasound recorded (up to 1 day)

  • Need for intervention by a physician

    Assessed at the time of discharge and reflecting entire duration of hospitalization (up to 7 days)

  • Serious complications/ morbidity

    Assessed at the time of discharge and reflecting entire duration of hospitalization (up to 7 days)

  • Adverse events

    up to 7 days after discharge

Study Arms (2)

Women receiving abortion care by physicians

ACTIVE COMPARATOR

Patients who receive second trimester medical abortion care from a physician.

Procedure: Provider type: Physicians

Women receiving abortion care from midlevel providers

EXPERIMENTAL

Patients who receive second trimester medical abortion care from a midlevel provider.

Procedure: Provider type: Midlevel Providers

Interventions

In this cohort, women will receive second trimester medical abortion care from physicians

Women receiving abortion care by physicians

In this cohort, women will receive second trimester medical abortion care from midlevel providers.

Women receiving abortion care from midlevel providers

Eligibility Criteria

Age16 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Willing and able to give consent for participation
  • Intrauterine pregnancy with confirmed gestational age \>13 weeks and \<20 weeks
  • Presenting for induced abortion at Michu Clinic
  • Speaker of Amharic or Oromo

You may not qualify if:

  • Women unable to give consent for participation
  • Gestational age \<13 or \>20 weeks
  • Adolescents aged less than 16 years
  • Women with an allergy to or contraindications to mifepristone or misoprostol
  • Women with a history of more than one previous hysterotomy
  • Women seeking treatment for incomplete abortion, intrauterine fetal demise, or postabortion care
  • Women with chronic hypertension or adrenal failure
  • Women on chronic steroid treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Paul's Hospital Millennium Medical College

Addis Ababa, Ethiopia

Location

Study Officials

  • Nathalie Kapp, MD, MPH

    Ipas

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The investigators propose a randomized, controlled, non-inferiority study comparing management of medical abortion by either nurse midwives or physicians for women undergoing induced abortion at a gestational ages \> 13 weeks.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 22, 2019

First Posted

November 29, 2019

Study Start

February 17, 2020

Primary Completion

February 24, 2021

Study Completion

March 3, 2021

Last Updated

September 20, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations